Ignite Creation Date:
2025-12-24 @ 5:14 PM
Ignite Modification Date:
2026-06-29 @ 10:54 PM
Study NCT ID:
NCT04381650
Status:
COMPLETED
Last Update Posted:
2025-12-10
First Post:
2020-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors
Sponsor:
Takeda
Organization: